The goal of treatment is to reduce the thickness of the blood and to prevent bleeding and clotting.
A method called phlebotomy is used to decrease blood thickness. One pint of blood is removed weekly until the hematocrit level is less than 45, then therapy is continued as needed.
Occasionally, chemotherapy (specifically hydroxyurea) may be given to suppress the bone marrow. Interferon may be given to lower blood counts. A medicine called anegrelide may be given to lower platelet counts.
The use of blood thinners (such as aspirin) is controversial because it may cause stomach bleeding.
Support Groups:
Expectations (prognosis):
The disease usually develops slowly, and most patients do not experience any problems related to the disease after being diagnosed. However, the abnormal bone marrow cells may begin to grow uncontrollably in some patients leading to acute myelogenous leukemia . This occurs in a minority of cases.
Patients with polycythemia vera also have an increased tendency to form blood clots that can result in strokes or heart attacks . Some patients may experience abnormal bleeding because their platelets are abnormal.
Call your health care provider if symptoms of polycythemia vera develop.
Prevention:
Review Date: 8/28/2007 Reviewed By: Stephen Grund, M.D. Ph.D., Chief of Hematology/Oncology and Director of the George Bray Cancer Center at New Britain General Hospital, New Britain, CT. Review provided by VeriMed Healthcare Network.